Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Seizures × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 161 Breast Neoplasms 111 Colorectal Neoplasms 76 Neoplasms 64 Lung Neoplasms 60 Pancreatic Neoplasms 55 Neoplasm Metastasis 51 Stomach Neoplasms 50 Ovarian Neoplasms 45 Rectal Neoplasms 43 Esophageal Squamous Cell Carcinoma 38 Esophageal Neoplasms 38 Head and Neck Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 32 Leukemia, Myeloid, Acute 31 Recurrence 25 Triple Negative Breast Neoplasms 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Small Cell Lung Carcinoma 23 Colonic Neoplasms 23 Nasopharyngeal Carcinoma 22 Glioblastoma 22 Uterine Cervical Neoplasms 21 Lymphoma 21 Lymphoma, Non-Hodgkin 20 Fallopian Tube Neoplasms 20 Prostatic Neoplasms 17 Melanoma 17 Sarcoma 16 Leukemia 16

Interventions

Levetiracetam 6 Cannabidiol 5 perampanel 2 Tranexamic Acid 2 Standard of Care 2 Everolimus 2 ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Temozolomide 1 Spironolactone 1 Solutions 1 Sodium Chloride 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Remifentanil 1 Propofol 1 Pregabalin 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04450160 2020-06-29

AEO

MetVital, Inc.

Phase 2 Unknown

Glioblastoma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡